{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:29:44Z","timestamp":1785439784148,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T00:00:00Z","timestamp":1378944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00330-013-3010-z","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T11:09:34Z","timestamp":1378897774000},"page":"277-287","source":"Crossref","is-referenced-by-count":124,"title":["Evaluation of Crohn\u2019s disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin"],"prefix":"10.1007","volume":"24","author":[{"given":"Jesica C.","family":"Makanyanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Pends\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Dikaios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Helbren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shonit","family":"Punwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Halligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,12]]},"reference":[{"key":"3010_CR1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","volume":"4","author":"A Dignass","year":"2010","unstructured":"Dignass A, Van Assche G, Lindsay JO et al (2010) The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: current management. J Crohn\u2019s Colitis 4:28\u201362","journal-title":"J Crohn\u2019s Colitis"},{"key":"3010_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ajg.2008.168","volume":"104","author":"GR Lichtenstein","year":"2009","unstructured":"Lichtenstein GR, Hanauer SB, Sandborn WJ (2009) Management of Crohn\u2019s disease in adults. Am J Gastroenterol 104:465\u2013483","journal-title":"Am J Gastroenterol"},{"key":"3010_CR3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","volume":"6","author":"J Jones","year":"2008","unstructured":"Jones J, Loftus EV, Panaccione R et al (2008) Relationships between disease activity and serum and fecal biomarkers in patients with Crohn\u2019s disease. Clin Gastroenterol Hepatol 6:1218\u20131224","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3010_CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","volume":"103","author":"J Langhorst","year":"2008","unstructured":"Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ (2008) Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 103:162\u2013169","journal-title":"Am J Gastroenterol"},{"key":"3010_CR5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365529950172835","volume":"34","author":"AG R\u00f8seth","year":"1999","unstructured":"R\u00f8seth AG, Schmidt PN, Fagerhol MK (1999) Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 34:50\u201354","journal-title":"Scand J Gastroenterol"},{"key":"3010_CR6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ajg.2009.545","volume":"105","author":"AM Schoepfer","year":"2009","unstructured":"Schoepfer AM, Beglinger C, Straumann A et al (2009) Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn\u2019s disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 105:162\u2013169","journal-title":"Am J Gastroenterol"},{"key":"3010_CR7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2008.03835.x","volume":"28","author":"T Sipponen","year":"2008","unstructured":"Sipponen T, K\u00e4rkk\u00e4inen P, Savilahti E et al (2008) Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn\u2019s disease and histological findings. Aliment Pharmacol Ther 28:1221\u20131229","journal-title":"Aliment Pharmacol Ther"},{"key":"3010_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ibd.20312","volume":"14","author":"T Sipponen","year":"2008","unstructured":"Sipponen T, Savilahti E, Kolho K-L, Nuutinen H, Turunen U, F\u00e4rkkil\u00e4 M (2008) Crohn\u2019s disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 14:40\u201346","journal-title":"Inflamm Bowel Dis"},{"key":"3010_CR9","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ejrad.2011.07.013","volume":"81","author":"MJ Steward","year":"2012","unstructured":"Steward MJ, Punwani S, Proctor I et al (2012) Non-perforating small bowel Crohn\u2019s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81:2080\u20132088","journal-title":"Eur J Radiol"},{"key":"3010_CR10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ibd.21414","volume":"17","author":"M Zappa","year":"2011","unstructured":"Zappa M, Stefanescu C, Cazals-Hatem D et al (2011) Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn\u2019s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 17:984\u2013993","journal-title":"Inflamm Bowel Dis"},{"key":"3010_CR11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/gut.2008.167957","volume":"58","author":"J Rimola","year":"2009","unstructured":"Rimola J, Rodriguez S, Garc\u00eda-Bosch O et al (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn\u2019s disease. Gut 58:1113\u20131120","journal-title":"Gut"},{"key":"3010_CR12","first-page":"11","volume":"55","author":"A Lasocki","year":"2011","unstructured":"Lasocki A, Pitman A, Williams R, Lui B, Kalade AV, Farish S (2011) Relative efficacy of different MRI signs in diagnosing active Crohn\u2019s disease, compared against a histological gold standard. J Magn Reson Imaging 55:11\u201319","journal-title":"J Magn Reson Imaging"},{"key":"3010_CR13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2214\/AJR.07.2427","volume":"189","author":"TA Jaffe","year":"2007","unstructured":"Jaffe TA, Gaca AM, Delaney S et al (2007) Radiation doses from small-bowel follow-through and abdominopelvic MDCT in Crohn\u2019s disease. AJR Am J Roentgenol 189:1015\u20131022","journal-title":"AJR Am J Roentgenol"},{"key":"3010_CR14","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1572-0241.2008.01920.x","volume":"103","author":"J Peloquin","year":"2008","unstructured":"Peloquin J, Pardi D, Sandborn W et al (2008) Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 103:2015\u20132022","journal-title":"Am J Gastroenterol"},{"key":"3010_CR15","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/ibd.21551","volume":"17","author":"J Rimola","year":"2011","unstructured":"Rimola J, Ord\u00e1s I, Rodriguez S et al (2011) Magnetic resonance imaging for evaluation of Crohn\u2019s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 17:1759\u20131768","journal-title":"Inflamm Bowel Dis"},{"key":"3010_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1148\/radiol.2512081292","volume":"251","author":"SA Taylor","year":"2009","unstructured":"Taylor SA, Punwani S, Rodriguez-Justo M et al (2009) Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination\u2014Pilot study1. Radiology 251:369\u2013379","journal-title":"Radiology"},{"key":"3010_CR17","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1016\/j.ejrad.2010.12.075","volume":"80","author":"MLW Ziech","year":"2010","unstructured":"Ziech MLW, Bipat S, Roelofs J et al (2010) Retrospective comparison of magnetic resonance imaging features and histopathology in Crohn\u2019s disease patients. Eur J Radiol 80:e299\u2013e305","journal-title":"Eur J Radiol"},{"key":"3010_CR18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"R Harvey","year":"1980","unstructured":"Harvey R, Bradshaw J (1980) A simple index of Crohn\u2019s disease activity. Lancet 1:514","journal-title":"Lancet"},{"issue":"Suppl A","key":"3010_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5\u201336","journal-title":"Can J Gastroenterol"},{"key":"3010_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1148\/radiol.2281020161","volume":"228","author":"T Lauenstein","year":"2003","unstructured":"Lauenstein T, Schneemann H (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228:279\u2013283","journal-title":"Radiology"},{"key":"3010_CR21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/gut.2003.037085","volume":"54","author":"WM Ajaj","year":"2005","unstructured":"Ajaj WM, Lauenstein TC, Pelster G et al (2005) Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut 54:257\u2013263","journal-title":"Gut"},{"key":"3010_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1148\/radiol.2291021151","volume":"229","author":"SA Taylor","year":"2003","unstructured":"Taylor SA, Halligan S, Goh V et al (2003) Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. Radiology 229:99\u2013108","journal-title":"Radiology"},{"key":"3010_CR23","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/gut.52.12.1738","volume":"52","author":"W Ajaj","year":"2003","unstructured":"Ajaj W, Pelster G, Treichel U, Vogt F (2003) Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology. Gut 52:1738\u20131744","journal-title":"Gut"},{"key":"3010_CR24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1148\/rg.302095028","volume":"30","author":"DJM Tolan","year":"2010","unstructured":"Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30:367\u2013384","journal-title":"Radiographics"},{"key":"3010_CR25","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1016\/j.ejrad.2011.05.033","volume":"81","author":"MLW Ziech","year":"2012","unstructured":"Ziech MLW, Bossuyt PMM, Laghi A, Lauenstein TC, Taylor SA, Stoker J (2012) Grading luminal Crohn\u2019s disease: which MRI features are considered as important? Eur J Radiol 81:e467\u2013e472","journal-title":"Eur J Radiol"},{"key":"3010_CR26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/00365521.2012.660542","volume":"47","author":"C-G Bj\u00f6rkesten","year":"2012","unstructured":"Bj\u00f6rkesten C-G, Nieminen U, Turunen U, Arkkila P, Sipponen T, F\u00e4rkkil\u00e4 M (2012) Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn\u2019s disease. Scand J Gastroenterol 47:528\u2013537","journal-title":"Scand J Gastroenterol"},{"key":"3010_CR27","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s00261-011-9820-z","volume":"37","author":"J Rimola","year":"2012","unstructured":"Rimola J, Ord\u00e1s I, Rodr\u00edguez S, Ricart E, Pan\u00e9s J (2012) Imaging indexes of activity and severity for Crohn\u2019s disease: current status and future trends. Abdom Imaging 37:958\u2013966","journal-title":"Abdom Imaging"},{"key":"3010_CR28","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ibd.20490","volume":"14","author":"T Sipponen","year":"2008","unstructured":"Sipponen T, Savilahti E, K\u00e4rkk\u00e4inen P et al (2008) Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn\u2019s disease. Inflamm Bowel Dis 14:1392\u20131398","journal-title":"Inflamm Bowel Dis"},{"key":"3010_CR29","first-page":"622","volume":"118","author":"P Eder","year":"2008","unstructured":"Eder P, Stawczyk-Eder K, Krela-Ka\u017amierczak I, Linke K (2008) Clinical utility of the assessment of fecal calprotectin in Le\u015bniowski-Crohn\u2019s disease. Pol Arch Med Wewn 118:622\u2013626","journal-title":"Pol Arch Med Wewn"},{"key":"3010_CR30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2036.2004.02128.x","volume":"20","author":"S Dolwani","year":"2004","unstructured":"Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB (2004) Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 20:615\u2013621","journal-title":"Aliment Pharmacol Ther"},{"key":"3010_CR31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/00365521.2010.539253","volume":"46","author":"MH L\u00f6nnkvist","year":"2011","unstructured":"L\u00f6nnkvist MH, Theodorsson E, Holst M, Ljung T, Hellstr\u00f6m PM (2011) Blood chemistry markers for evaluation of inflammatory activity in Crohn\u2019s disease during infliximab therapy. Scand J Gastroenterol 46:420\u2013427","journal-title":"Scand J Gastroenterol"},{"key":"3010_CR32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.crohns.2009.09.008","volume":"4","author":"V Garc\u00eda-S\u00e1nchez","year":"2010","unstructured":"Garc\u00eda-S\u00e1nchez V, Iglesias-Flores E, Gonz\u00e1lez R et al (2010) Does fecal calprotectin predict relapse in patients with Crohn\u2019s disease and ulcerative colitis? J Crohn\u2019s and Colitis 4:144\u2013152","journal-title":"J Crohn\u2019s and Colitis"},{"key":"3010_CR33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MEG.0b013e32832bab49","volume":"22","author":"L Kallel","year":"2010","unstructured":"Kallel L, Ayadi I, Matri S et al (2010) Fecal calprotectin is a predictive marker of relapse in Crohn\u2019s disease involving the colon: a prospective study. Eur J Gastroenterol Hepatol 22:340\u2013345","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3010_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2011.09.034","volume":"142","author":"E Louis","year":"2012","unstructured":"Louis E, Mary J-Y, Vernier-Massouille G et al (2012) Maintenance of remission among patients with Crohn\u2019s disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 142:63\u201370","journal-title":"Gastroenterology"},{"key":"3010_CR35","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1572-0241.2008.01870.x","volume":"103","author":"R D\u2019Inc\u00e0","year":"2008","unstructured":"D\u2019Inc\u00e0 R, Dal Pont E, Di Leo V et al (2008) Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol 103:2007\u20132014","journal-title":"Am J Gastroenterol"},{"key":"3010_CR36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/bjs.6593","volume":"96","author":"CA Lamb","year":"2009","unstructured":"Lamb CA, Mohiuddin MK, Gicquel J et al (2009) Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn\u2019s disease. Br J Surg 96:663\u2013674","journal-title":"Br J Surg"},{"key":"3010_CR37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/00365520903483650","volume":"45","author":"T Sipponen","year":"2010","unstructured":"Sipponen T, Bj\u00f6rkesten C-GAF, F\u00e4rkkil\u00e4 M, Nuutinen H, Savilahti E, Kolho K-L (2010) Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn\u2019s disease treatment. Scand J Gastroenterol 45:325\u2013331","journal-title":"Scand J Gastroenterol"},{"key":"3010_CR38","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ibd.21506","volume":"17","author":"B Pariente","year":"2011","unstructured":"Pariente B, Cosnes J, Danese S et al (2011) Development of the Crohn\u2019s disease digestive damage score, the L\u00e9mann score. Inflamm Bowel Dis 17:1415\u20131422","journal-title":"Inflamm Bowel Dis"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-013-3010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-013-3010-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-013-3010-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:02:03Z","timestamp":1559044923000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-013-3010-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,12]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["3010"],"URL":"https:\/\/doi.org\/10.1007\/s00330-013-3010-z","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,12]]}}}